Global mRNA Shingles Vaccine Market Growth 2025-2031
The global mRNA Shingles Vaccine market size is predicted to grow from US$ 346 million in 2025 to US$ 480 million in 2031; it is expected to grow at a CAGR of 5.6% from 2025 to 2031.
The mRNA shingles vaccine is a vaccine developed using mRNA technology to prevent herpes zoster, commonly known as 'shingles'. Herpes zoster is caused by the reactivation of the varicella-zoster virus (VZV), typically manifesting as painful blisters on the skin. The mRNA shingles vaccine introduces mRNA encoding specific antigen proteins of the varicella-zoster virus into the human body, inducing human cells to produce these antigen proteins and subsequently stimulating the immune response to form long-term immune protection against the varicella-zoster virus. This vaccine offers advantages such as high efficacy, safety, and a short development cycle, providing an effective immune barrier for susceptible populations.
United States market for mRNA Shingles Vaccine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for mRNA Shingles Vaccine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for mRNA Shingles Vaccine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key mRNA Shingles Vaccine players cover AIM Vaccine, Innorna, Moderna, Pfizer, SINOVAC, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “mRNA Shingles Vaccine Industry Forecast” looks at past sales and reviews total world mRNA Shingles Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected mRNA Shingles Vaccine sales for 2025 through 2031. With mRNA Shingles Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA Shingles Vaccine industry.
This Insight Report provides a comprehensive analysis of the global mRNA Shingles Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on mRNA Shingles Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global mRNA Shingles Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Shingles Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA Shingles Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Shingles Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global mRNA Shingles Vaccine market?
What factors are driving mRNA Shingles Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do mRNA Shingles Vaccine market opportunities vary by end market size?
How does mRNA Shingles Vaccine break out by Type, by Application?
The mRNA shingles vaccine is a vaccine developed using mRNA technology to prevent herpes zoster, commonly known as 'shingles'. Herpes zoster is caused by the reactivation of the varicella-zoster virus (VZV), typically manifesting as painful blisters on the skin. The mRNA shingles vaccine introduces mRNA encoding specific antigen proteins of the varicella-zoster virus into the human body, inducing human cells to produce these antigen proteins and subsequently stimulating the immune response to form long-term immune protection against the varicella-zoster virus. This vaccine offers advantages such as high efficacy, safety, and a short development cycle, providing an effective immune barrier for susceptible populations.
United States market for mRNA Shingles Vaccine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for mRNA Shingles Vaccine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for mRNA Shingles Vaccine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key mRNA Shingles Vaccine players cover AIM Vaccine, Innorna, Moderna, Pfizer, SINOVAC, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “mRNA Shingles Vaccine Industry Forecast” looks at past sales and reviews total world mRNA Shingles Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected mRNA Shingles Vaccine sales for 2025 through 2031. With mRNA Shingles Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA Shingles Vaccine industry.
This Insight Report provides a comprehensive analysis of the global mRNA Shingles Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on mRNA Shingles Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global mRNA Shingles Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Shingles Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA Shingles Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Shingles Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Non Self Amplifying Type
- Self-Amplifying Type
- Hospital
- Clinic
- CDC
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AIM Vaccine
- Innorna
- Moderna
- Pfizer
- SINOVAC
- BioNTech
- Immorna
- Rhegen
- GSK
What is the 10-year outlook for the global mRNA Shingles Vaccine market?
What factors are driving mRNA Shingles Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do mRNA Shingles Vaccine market opportunities vary by end market size?
How does mRNA Shingles Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global mRNA Shingles Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for mRNA Shingles Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for mRNA Shingles Vaccine by Country/Region, 2020, 2024 & 2031
2.2 mRNA Shingles Vaccine Segment by Type
2.2.1 Non Self Amplifying Type
2.2.2 Self-Amplifying Type
2.3 mRNA Shingles Vaccine Sales by Type
2.3.1 Global mRNA Shingles Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global mRNA Shingles Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global mRNA Shingles Vaccine Sale Price by Type (2020-2025)
2.4 mRNA Shingles Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 CDC
2.4.4 Others
2.5 mRNA Shingles Vaccine Sales by Application
2.5.1 Global mRNA Shingles Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global mRNA Shingles Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global mRNA Shingles Vaccine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global mRNA Shingles Vaccine Breakdown Data by Company
3.1.1 Global mRNA Shingles Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global mRNA Shingles Vaccine Sales Market Share by Company (2020-2025)
3.2 Global mRNA Shingles Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global mRNA Shingles Vaccine Revenue by Company (2020-2025)
3.2.2 Global mRNA Shingles Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global mRNA Shingles Vaccine Sale Price by Company
3.4 Key Manufacturers mRNA Shingles Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers mRNA Shingles Vaccine Product Location Distribution
3.4.2 Players mRNA Shingles Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MRNA SHINGLES VACCINE BY GEOGRAPHIC REGION
4.1 World Historic mRNA Shingles Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global mRNA Shingles Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global mRNA Shingles Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic mRNA Shingles Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global mRNA Shingles Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global mRNA Shingles Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas mRNA Shingles Vaccine Sales Growth
4.4 APAC mRNA Shingles Vaccine Sales Growth
4.5 Europe mRNA Shingles Vaccine Sales Growth
4.6 Middle East & Africa mRNA Shingles Vaccine Sales Growth
5 AMERICAS
5.1 Americas mRNA Shingles Vaccine Sales by Country
5.1.1 Americas mRNA Shingles Vaccine Sales by Country (2020-2025)
5.1.2 Americas mRNA Shingles Vaccine Revenue by Country (2020-2025)
5.2 Americas mRNA Shingles Vaccine Sales by Type (2020-2025)
5.3 Americas mRNA Shingles Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Shingles Vaccine Sales by Region
6.1.1 APAC mRNA Shingles Vaccine Sales by Region (2020-2025)
6.1.2 APAC mRNA Shingles Vaccine Revenue by Region (2020-2025)
6.2 APAC mRNA Shingles Vaccine Sales by Type (2020-2025)
6.3 APAC mRNA Shingles Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe mRNA Shingles Vaccine by Country
7.1.1 Europe mRNA Shingles Vaccine Sales by Country (2020-2025)
7.1.2 Europe mRNA Shingles Vaccine Revenue by Country (2020-2025)
7.2 Europe mRNA Shingles Vaccine Sales by Type (2020-2025)
7.3 Europe mRNA Shingles Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa mRNA Shingles Vaccine by Country
8.1.1 Middle East & Africa mRNA Shingles Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa mRNA Shingles Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa mRNA Shingles Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa mRNA Shingles Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of mRNA Shingles Vaccine
10.3 Manufacturing Process Analysis of mRNA Shingles Vaccine
10.4 Industry Chain Structure of mRNA Shingles Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 mRNA Shingles Vaccine Distributors
11.3 mRNA Shingles Vaccine Customer
12 WORLD FORECAST REVIEW FOR MRNA SHINGLES VACCINE BY GEOGRAPHIC REGION
12.1 Global mRNA Shingles Vaccine Market Size Forecast by Region
12.1.1 Global mRNA Shingles Vaccine Forecast by Region (2026-2031)
12.1.2 Global mRNA Shingles Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global mRNA Shingles Vaccine Forecast by Type (2026-2031)
12.7 Global mRNA Shingles Vaccine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 AIM Vaccine
13.1.1 AIM Vaccine Company Information
13.1.2 AIM Vaccine mRNA Shingles Vaccine Product Portfolios and Specifications
13.1.3 AIM Vaccine mRNA Shingles Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 AIM Vaccine Main Business Overview
13.1.5 AIM Vaccine Latest Developments
13.2 Innorna
13.2.1 Innorna Company Information
13.2.2 Innorna mRNA Shingles Vaccine Product Portfolios and Specifications
13.2.3 Innorna mRNA Shingles Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Innorna Main Business Overview
13.2.5 Innorna Latest Developments
13.3 Moderna
13.3.1 Moderna Company Information
13.3.2 Moderna mRNA Shingles Vaccine Product Portfolios and Specifications
13.3.3 Moderna mRNA Shingles Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Moderna Main Business Overview
13.3.5 Moderna Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer mRNA Shingles Vaccine Product Portfolios and Specifications
13.4.3 Pfizer mRNA Shingles Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 SINOVAC
13.5.1 SINOVAC Company Information
13.5.2 SINOVAC mRNA Shingles Vaccine Product Portfolios and Specifications
13.5.3 SINOVAC mRNA Shingles Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 SINOVAC Main Business Overview
13.5.5 SINOVAC Latest Developments
13.6 BioNTech
13.6.1 BioNTech Company Information
13.6.2 BioNTech mRNA Shingles Vaccine Product Portfolios and Specifications
13.6.3 BioNTech mRNA Shingles Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 BioNTech Main Business Overview
13.6.5 BioNTech Latest Developments
13.7 Immorna
13.7.1 Immorna Company Information
13.7.2 Immorna mRNA Shingles Vaccine Product Portfolios and Specifications
13.7.3 Immorna mRNA Shingles Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Immorna Main Business Overview
13.7.5 Immorna Latest Developments
13.8 Rhegen
13.8.1 Rhegen Company Information
13.8.2 Rhegen mRNA Shingles Vaccine Product Portfolios and Specifications
13.8.3 Rhegen mRNA Shingles Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Rhegen Main Business Overview
13.8.5 Rhegen Latest Developments
13.9 GSK
13.9.1 GSK Company Information
13.9.2 GSK mRNA Shingles Vaccine Product Portfolios and Specifications
13.9.3 GSK mRNA Shingles Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 GSK Main Business Overview
13.9.5 GSK Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global mRNA Shingles Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for mRNA Shingles Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for mRNA Shingles Vaccine by Country/Region, 2020, 2024 & 2031
2.2 mRNA Shingles Vaccine Segment by Type
2.2.1 Non Self Amplifying Type
2.2.2 Self-Amplifying Type
2.3 mRNA Shingles Vaccine Sales by Type
2.3.1 Global mRNA Shingles Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global mRNA Shingles Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global mRNA Shingles Vaccine Sale Price by Type (2020-2025)
2.4 mRNA Shingles Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 CDC
2.4.4 Others
2.5 mRNA Shingles Vaccine Sales by Application
2.5.1 Global mRNA Shingles Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global mRNA Shingles Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global mRNA Shingles Vaccine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global mRNA Shingles Vaccine Breakdown Data by Company
3.1.1 Global mRNA Shingles Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global mRNA Shingles Vaccine Sales Market Share by Company (2020-2025)
3.2 Global mRNA Shingles Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global mRNA Shingles Vaccine Revenue by Company (2020-2025)
3.2.2 Global mRNA Shingles Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global mRNA Shingles Vaccine Sale Price by Company
3.4 Key Manufacturers mRNA Shingles Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers mRNA Shingles Vaccine Product Location Distribution
3.4.2 Players mRNA Shingles Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MRNA SHINGLES VACCINE BY GEOGRAPHIC REGION
4.1 World Historic mRNA Shingles Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global mRNA Shingles Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global mRNA Shingles Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic mRNA Shingles Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global mRNA Shingles Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global mRNA Shingles Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas mRNA Shingles Vaccine Sales Growth
4.4 APAC mRNA Shingles Vaccine Sales Growth
4.5 Europe mRNA Shingles Vaccine Sales Growth
4.6 Middle East & Africa mRNA Shingles Vaccine Sales Growth
5 AMERICAS
5.1 Americas mRNA Shingles Vaccine Sales by Country
5.1.1 Americas mRNA Shingles Vaccine Sales by Country (2020-2025)
5.1.2 Americas mRNA Shingles Vaccine Revenue by Country (2020-2025)
5.2 Americas mRNA Shingles Vaccine Sales by Type (2020-2025)
5.3 Americas mRNA Shingles Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Shingles Vaccine Sales by Region
6.1.1 APAC mRNA Shingles Vaccine Sales by Region (2020-2025)
6.1.2 APAC mRNA Shingles Vaccine Revenue by Region (2020-2025)
6.2 APAC mRNA Shingles Vaccine Sales by Type (2020-2025)
6.3 APAC mRNA Shingles Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe mRNA Shingles Vaccine by Country
7.1.1 Europe mRNA Shingles Vaccine Sales by Country (2020-2025)
7.1.2 Europe mRNA Shingles Vaccine Revenue by Country (2020-2025)
7.2 Europe mRNA Shingles Vaccine Sales by Type (2020-2025)
7.3 Europe mRNA Shingles Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa mRNA Shingles Vaccine by Country
8.1.1 Middle East & Africa mRNA Shingles Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa mRNA Shingles Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa mRNA Shingles Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa mRNA Shingles Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of mRNA Shingles Vaccine
10.3 Manufacturing Process Analysis of mRNA Shingles Vaccine
10.4 Industry Chain Structure of mRNA Shingles Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 mRNA Shingles Vaccine Distributors
11.3 mRNA Shingles Vaccine Customer
12 WORLD FORECAST REVIEW FOR MRNA SHINGLES VACCINE BY GEOGRAPHIC REGION
12.1 Global mRNA Shingles Vaccine Market Size Forecast by Region
12.1.1 Global mRNA Shingles Vaccine Forecast by Region (2026-2031)
12.1.2 Global mRNA Shingles Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global mRNA Shingles Vaccine Forecast by Type (2026-2031)
12.7 Global mRNA Shingles Vaccine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 AIM Vaccine
13.1.1 AIM Vaccine Company Information
13.1.2 AIM Vaccine mRNA Shingles Vaccine Product Portfolios and Specifications
13.1.3 AIM Vaccine mRNA Shingles Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 AIM Vaccine Main Business Overview
13.1.5 AIM Vaccine Latest Developments
13.2 Innorna
13.2.1 Innorna Company Information
13.2.2 Innorna mRNA Shingles Vaccine Product Portfolios and Specifications
13.2.3 Innorna mRNA Shingles Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Innorna Main Business Overview
13.2.5 Innorna Latest Developments
13.3 Moderna
13.3.1 Moderna Company Information
13.3.2 Moderna mRNA Shingles Vaccine Product Portfolios and Specifications
13.3.3 Moderna mRNA Shingles Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Moderna Main Business Overview
13.3.5 Moderna Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer mRNA Shingles Vaccine Product Portfolios and Specifications
13.4.3 Pfizer mRNA Shingles Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 SINOVAC
13.5.1 SINOVAC Company Information
13.5.2 SINOVAC mRNA Shingles Vaccine Product Portfolios and Specifications
13.5.3 SINOVAC mRNA Shingles Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 SINOVAC Main Business Overview
13.5.5 SINOVAC Latest Developments
13.6 BioNTech
13.6.1 BioNTech Company Information
13.6.2 BioNTech mRNA Shingles Vaccine Product Portfolios and Specifications
13.6.3 BioNTech mRNA Shingles Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 BioNTech Main Business Overview
13.6.5 BioNTech Latest Developments
13.7 Immorna
13.7.1 Immorna Company Information
13.7.2 Immorna mRNA Shingles Vaccine Product Portfolios and Specifications
13.7.3 Immorna mRNA Shingles Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Immorna Main Business Overview
13.7.5 Immorna Latest Developments
13.8 Rhegen
13.8.1 Rhegen Company Information
13.8.2 Rhegen mRNA Shingles Vaccine Product Portfolios and Specifications
13.8.3 Rhegen mRNA Shingles Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Rhegen Main Business Overview
13.8.5 Rhegen Latest Developments
13.9 GSK
13.9.1 GSK Company Information
13.9.2 GSK mRNA Shingles Vaccine Product Portfolios and Specifications
13.9.3 GSK mRNA Shingles Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 GSK Main Business Overview
13.9.5 GSK Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. mRNA Shingles Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. mRNA Shingles Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Non Self Amplifying Type
Table 4. Major Players of Self-Amplifying Type
Table 5. Global mRNA Shingles Vaccine Sales by Type (2020-2025) & (Units)
Table 6. Global mRNA Shingles Vaccine Sales Market Share by Type (2020-2025)
Table 7. Global mRNA Shingles Vaccine Revenue by Type (2020-2025) & ($ million)
Table 8. Global mRNA Shingles Vaccine Revenue Market Share by Type (2020-2025)
Table 9. Global mRNA Shingles Vaccine Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global mRNA Shingles Vaccine Sale by Application (2020-2025) & (Units)
Table 11. Global mRNA Shingles Vaccine Sale Market Share by Application (2020-2025)
Table 12. Global mRNA Shingles Vaccine Revenue by Application (2020-2025) & ($ million)
Table 13. Global mRNA Shingles Vaccine Revenue Market Share by Application (2020-2025)
Table 14. Global mRNA Shingles Vaccine Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global mRNA Shingles Vaccine Sales by Company (2020-2025) & (Units)
Table 16. Global mRNA Shingles Vaccine Sales Market Share by Company (2020-2025)
Table 17. Global mRNA Shingles Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global mRNA Shingles Vaccine Revenue Market Share by Company (2020-2025)
Table 19. Global mRNA Shingles Vaccine Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers mRNA Shingles Vaccine Producing Area Distribution and Sales Area
Table 21. Players mRNA Shingles Vaccine Products Offered
Table 22. mRNA Shingles Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global mRNA Shingles Vaccine Sales by Geographic Region (2020-2025) & (Units)
Table 26. Global mRNA Shingles Vaccine Sales Market Share Geographic Region (2020-2025)
Table 27. Global mRNA Shingles Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global mRNA Shingles Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global mRNA Shingles Vaccine Sales by Country/Region (2020-2025) & (Units)
Table 30. Global mRNA Shingles Vaccine Sales Market Share by Country/Region (2020-2025)
Table 31. Global mRNA Shingles Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global mRNA Shingles Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas mRNA Shingles Vaccine Sales by Country (2020-2025) & (Units)
Table 34. Americas mRNA Shingles Vaccine Sales Market Share by Country (2020-2025)
Table 35. Americas mRNA Shingles Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas mRNA Shingles Vaccine Sales by Type (2020-2025) & (Units)
Table 37. Americas mRNA Shingles Vaccine Sales by Application (2020-2025) & (Units)
Table 38. APAC mRNA Shingles Vaccine Sales by Region (2020-2025) & (Units)
Table 39. APAC mRNA Shingles Vaccine Sales Market Share by Region (2020-2025)
Table 40. APAC mRNA Shingles Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC mRNA Shingles Vaccine Sales by Type (2020-2025) & (Units)
Table 42. APAC mRNA Shingles Vaccine Sales by Application (2020-2025) & (Units)
Table 43. Europe mRNA Shingles Vaccine Sales by Country (2020-2025) & (Units)
Table 44. Europe mRNA Shingles Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe mRNA Shingles Vaccine Sales by Type (2020-2025) & (Units)
Table 46. Europe mRNA Shingles Vaccine Sales by Application (2020-2025) & (Units)
Table 47. Middle East & Africa mRNA Shingles Vaccine Sales by Country (2020-2025) & (Units)
Table 48. Middle East & Africa mRNA Shingles Vaccine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa mRNA Shingles Vaccine Sales by Type (2020-2025) & (Units)
Table 50. Middle East & Africa mRNA Shingles Vaccine Sales by Application (2020-2025) & (Units)
Table 51. Key Market Drivers & Growth Opportunities of mRNA Shingles Vaccine
Table 52. Key Market Challenges & Risks of mRNA Shingles Vaccine
Table 53. Key Industry Trends of mRNA Shingles Vaccine
Table 54. mRNA Shingles Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. mRNA Shingles Vaccine Distributors List
Table 57. mRNA Shingles Vaccine Customer List
Table 58. Global mRNA Shingles Vaccine Sales Forecast by Region (2026-2031) & (Units)
Table 59. Global mRNA Shingles Vaccine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas mRNA Shingles Vaccine Sales Forecast by Country (2026-2031) & (Units)
Table 61. Americas mRNA Shingles Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC mRNA Shingles Vaccine Sales Forecast by Region (2026-2031) & (Units)
Table 63. APAC mRNA Shingles Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe mRNA Shingles Vaccine Sales Forecast by Country (2026-2031) & (Units)
Table 65. Europe mRNA Shingles Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa mRNA Shingles Vaccine Sales Forecast by Country (2026-2031) & (Units)
Table 67. Middle East & Africa mRNA Shingles Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global mRNA Shingles Vaccine Sales Forecast by Type (2026-2031) & (Units)
Table 69. Global mRNA Shingles Vaccine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global mRNA Shingles Vaccine Sales Forecast by Application (2026-2031) & (Units)
Table 71. Global mRNA Shingles Vaccine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. AIM Vaccine Basic Information, mRNA Shingles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. AIM Vaccine mRNA Shingles Vaccine Product Portfolios and Specifications
Table 74. AIM Vaccine mRNA Shingles Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. AIM Vaccine Main Business
Table 76. AIM Vaccine Latest Developments
Table 77. Innorna Basic Information, mRNA Shingles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Innorna mRNA Shingles Vaccine Product Portfolios and Specifications
Table 79. Innorna mRNA Shingles Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Innorna Main Business
Table 81. Innorna Latest Developments
Table 82. Moderna Basic Information, mRNA Shingles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Moderna mRNA Shingles Vaccine Product Portfolios and Specifications
Table 84. Moderna mRNA Shingles Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Moderna Main Business
Table 86. Moderna Latest Developments
Table 87. Pfizer Basic Information, mRNA Shingles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Pfizer mRNA Shingles Vaccine Product Portfolios and Specifications
Table 89. Pfizer mRNA Shingles Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Pfizer Main Business
Table 91. Pfizer Latest Developments
Table 92. SINOVAC Basic Information, mRNA Shingles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. SINOVAC mRNA Shingles Vaccine Product Portfolios and Specifications
Table 94. SINOVAC mRNA Shingles Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. SINOVAC Main Business
Table 96. SINOVAC Latest Developments
Table 97. BioNTech Basic Information, mRNA Shingles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. BioNTech mRNA Shingles Vaccine Product Portfolios and Specifications
Table 99. BioNTech mRNA Shingles Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. BioNTech Main Business
Table 101. BioNTech Latest Developments
Table 102. Immorna Basic Information, mRNA Shingles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Immorna mRNA Shingles Vaccine Product Portfolios and Specifications
Table 104. Immorna mRNA Shingles Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Immorna Main Business
Table 106. Immorna Latest Developments
Table 107. Rhegen Basic Information, mRNA Shingles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Rhegen mRNA Shingles Vaccine Product Portfolios and Specifications
Table 109. Rhegen mRNA Shingles Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Rhegen Main Business
Table 111. Rhegen Latest Developments
Table 112. GSK Basic Information, mRNA Shingles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. GSK mRNA Shingles Vaccine Product Portfolios and Specifications
Table 114. GSK mRNA Shingles Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. GSK Main Business
Table 116. GSK Latest Developments
Table 1. mRNA Shingles Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. mRNA Shingles Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Non Self Amplifying Type
Table 4. Major Players of Self-Amplifying Type
Table 5. Global mRNA Shingles Vaccine Sales by Type (2020-2025) & (Units)
Table 6. Global mRNA Shingles Vaccine Sales Market Share by Type (2020-2025)
Table 7. Global mRNA Shingles Vaccine Revenue by Type (2020-2025) & ($ million)
Table 8. Global mRNA Shingles Vaccine Revenue Market Share by Type (2020-2025)
Table 9. Global mRNA Shingles Vaccine Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global mRNA Shingles Vaccine Sale by Application (2020-2025) & (Units)
Table 11. Global mRNA Shingles Vaccine Sale Market Share by Application (2020-2025)
Table 12. Global mRNA Shingles Vaccine Revenue by Application (2020-2025) & ($ million)
Table 13. Global mRNA Shingles Vaccine Revenue Market Share by Application (2020-2025)
Table 14. Global mRNA Shingles Vaccine Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global mRNA Shingles Vaccine Sales by Company (2020-2025) & (Units)
Table 16. Global mRNA Shingles Vaccine Sales Market Share by Company (2020-2025)
Table 17. Global mRNA Shingles Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global mRNA Shingles Vaccine Revenue Market Share by Company (2020-2025)
Table 19. Global mRNA Shingles Vaccine Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers mRNA Shingles Vaccine Producing Area Distribution and Sales Area
Table 21. Players mRNA Shingles Vaccine Products Offered
Table 22. mRNA Shingles Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global mRNA Shingles Vaccine Sales by Geographic Region (2020-2025) & (Units)
Table 26. Global mRNA Shingles Vaccine Sales Market Share Geographic Region (2020-2025)
Table 27. Global mRNA Shingles Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global mRNA Shingles Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global mRNA Shingles Vaccine Sales by Country/Region (2020-2025) & (Units)
Table 30. Global mRNA Shingles Vaccine Sales Market Share by Country/Region (2020-2025)
Table 31. Global mRNA Shingles Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global mRNA Shingles Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas mRNA Shingles Vaccine Sales by Country (2020-2025) & (Units)
Table 34. Americas mRNA Shingles Vaccine Sales Market Share by Country (2020-2025)
Table 35. Americas mRNA Shingles Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas mRNA Shingles Vaccine Sales by Type (2020-2025) & (Units)
Table 37. Americas mRNA Shingles Vaccine Sales by Application (2020-2025) & (Units)
Table 38. APAC mRNA Shingles Vaccine Sales by Region (2020-2025) & (Units)
Table 39. APAC mRNA Shingles Vaccine Sales Market Share by Region (2020-2025)
Table 40. APAC mRNA Shingles Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC mRNA Shingles Vaccine Sales by Type (2020-2025) & (Units)
Table 42. APAC mRNA Shingles Vaccine Sales by Application (2020-2025) & (Units)
Table 43. Europe mRNA Shingles Vaccine Sales by Country (2020-2025) & (Units)
Table 44. Europe mRNA Shingles Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe mRNA Shingles Vaccine Sales by Type (2020-2025) & (Units)
Table 46. Europe mRNA Shingles Vaccine Sales by Application (2020-2025) & (Units)
Table 47. Middle East & Africa mRNA Shingles Vaccine Sales by Country (2020-2025) & (Units)
Table 48. Middle East & Africa mRNA Shingles Vaccine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa mRNA Shingles Vaccine Sales by Type (2020-2025) & (Units)
Table 50. Middle East & Africa mRNA Shingles Vaccine Sales by Application (2020-2025) & (Units)
Table 51. Key Market Drivers & Growth Opportunities of mRNA Shingles Vaccine
Table 52. Key Market Challenges & Risks of mRNA Shingles Vaccine
Table 53. Key Industry Trends of mRNA Shingles Vaccine
Table 54. mRNA Shingles Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. mRNA Shingles Vaccine Distributors List
Table 57. mRNA Shingles Vaccine Customer List
Table 58. Global mRNA Shingles Vaccine Sales Forecast by Region (2026-2031) & (Units)
Table 59. Global mRNA Shingles Vaccine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas mRNA Shingles Vaccine Sales Forecast by Country (2026-2031) & (Units)
Table 61. Americas mRNA Shingles Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC mRNA Shingles Vaccine Sales Forecast by Region (2026-2031) & (Units)
Table 63. APAC mRNA Shingles Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe mRNA Shingles Vaccine Sales Forecast by Country (2026-2031) & (Units)
Table 65. Europe mRNA Shingles Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa mRNA Shingles Vaccine Sales Forecast by Country (2026-2031) & (Units)
Table 67. Middle East & Africa mRNA Shingles Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global mRNA Shingles Vaccine Sales Forecast by Type (2026-2031) & (Units)
Table 69. Global mRNA Shingles Vaccine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global mRNA Shingles Vaccine Sales Forecast by Application (2026-2031) & (Units)
Table 71. Global mRNA Shingles Vaccine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. AIM Vaccine Basic Information, mRNA Shingles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. AIM Vaccine mRNA Shingles Vaccine Product Portfolios and Specifications
Table 74. AIM Vaccine mRNA Shingles Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. AIM Vaccine Main Business
Table 76. AIM Vaccine Latest Developments
Table 77. Innorna Basic Information, mRNA Shingles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Innorna mRNA Shingles Vaccine Product Portfolios and Specifications
Table 79. Innorna mRNA Shingles Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Innorna Main Business
Table 81. Innorna Latest Developments
Table 82. Moderna Basic Information, mRNA Shingles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Moderna mRNA Shingles Vaccine Product Portfolios and Specifications
Table 84. Moderna mRNA Shingles Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Moderna Main Business
Table 86. Moderna Latest Developments
Table 87. Pfizer Basic Information, mRNA Shingles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Pfizer mRNA Shingles Vaccine Product Portfolios and Specifications
Table 89. Pfizer mRNA Shingles Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Pfizer Main Business
Table 91. Pfizer Latest Developments
Table 92. SINOVAC Basic Information, mRNA Shingles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. SINOVAC mRNA Shingles Vaccine Product Portfolios and Specifications
Table 94. SINOVAC mRNA Shingles Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. SINOVAC Main Business
Table 96. SINOVAC Latest Developments
Table 97. BioNTech Basic Information, mRNA Shingles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. BioNTech mRNA Shingles Vaccine Product Portfolios and Specifications
Table 99. BioNTech mRNA Shingles Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. BioNTech Main Business
Table 101. BioNTech Latest Developments
Table 102. Immorna Basic Information, mRNA Shingles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Immorna mRNA Shingles Vaccine Product Portfolios and Specifications
Table 104. Immorna mRNA Shingles Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Immorna Main Business
Table 106. Immorna Latest Developments
Table 107. Rhegen Basic Information, mRNA Shingles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Rhegen mRNA Shingles Vaccine Product Portfolios and Specifications
Table 109. Rhegen mRNA Shingles Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Rhegen Main Business
Table 111. Rhegen Latest Developments
Table 112. GSK Basic Information, mRNA Shingles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. GSK mRNA Shingles Vaccine Product Portfolios and Specifications
Table 114. GSK mRNA Shingles Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. GSK Main Business
Table 116. GSK Latest Developments
LIST OF FIGURES
Figure 1. Picture of mRNA Shingles Vaccine
Figure 2. mRNA Shingles Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global mRNA Shingles Vaccine Sales Growth Rate 2020-2031 (Units)
Figure 7. Global mRNA Shingles Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. mRNA Shingles Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. mRNA Shingles Vaccine Sales Market Share by Country/Region (2024)
Figure 10. mRNA Shingles Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Non Self Amplifying Type
Figure 12. Product Picture of Self-Amplifying Type
Figure 13. Global mRNA Shingles Vaccine Sales Market Share by Type in 2025
Figure 14. Global mRNA Shingles Vaccine Revenue Market Share by Type (2020-2025)
Figure 15. mRNA Shingles Vaccine Consumed in Hospital
Figure 16. Global mRNA Shingles Vaccine Market: Hospital (2020-2025) & (Units)
Figure 17. mRNA Shingles Vaccine Consumed in Clinic
Figure 18. Global mRNA Shingles Vaccine Market: Clinic (2020-2025) & (Units)
Figure 19. mRNA Shingles Vaccine Consumed in CDC
Figure 20. Global mRNA Shingles Vaccine Market: CDC (2020-2025) & (Units)
Figure 21. mRNA Shingles Vaccine Consumed in Others
Figure 22. Global mRNA Shingles Vaccine Market: Others (2020-2025) & (Units)
Figure 23. Global mRNA Shingles Vaccine Sale Market Share by Application (2024)
Figure 24. Global mRNA Shingles Vaccine Revenue Market Share by Application in 2025
Figure 25. mRNA Shingles Vaccine Sales by Company in 2025 (Units)
Figure 26. Global mRNA Shingles Vaccine Sales Market Share by Company in 2025
Figure 27. mRNA Shingles Vaccine Revenue by Company in 2025 ($ millions)
Figure 28. Global mRNA Shingles Vaccine Revenue Market Share by Company in 2025
Figure 29. Global mRNA Shingles Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global mRNA Shingles Vaccine Revenue Market Share by Geographic Region in 2025
Figure 31. Americas mRNA Shingles Vaccine Sales 2020-2025 (Units)
Figure 32. Americas mRNA Shingles Vaccine Revenue 2020-2025 ($ millions)
Figure 33. APAC mRNA Shingles Vaccine Sales 2020-2025 (Units)
Figure 34. APAC mRNA Shingles Vaccine Revenue 2020-2025 ($ millions)
Figure 35. Europe mRNA Shingles Vaccine Sales 2020-2025 (Units)
Figure 36. Europe mRNA Shingles Vaccine Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa mRNA Shingles Vaccine Sales 2020-2025 (Units)
Figure 38. Middle East & Africa mRNA Shingles Vaccine Revenue 2020-2025 ($ millions)
Figure 39. Americas mRNA Shingles Vaccine Sales Market Share by Country in 2025
Figure 40. Americas mRNA Shingles Vaccine Revenue Market Share by Country (2020-2025)
Figure 41. Americas mRNA Shingles Vaccine Sales Market Share by Type (2020-2025)
Figure 42. Americas mRNA Shingles Vaccine Sales Market Share by Application (2020-2025)
Figure 43. United States mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC mRNA Shingles Vaccine Sales Market Share by Region in 2025
Figure 48. APAC mRNA Shingles Vaccine Revenue Market Share by Region (2020-2025)
Figure 49. APAC mRNA Shingles Vaccine Sales Market Share by Type (2020-2025)
Figure 50. APAC mRNA Shingles Vaccine Sales Market Share by Application (2020-2025)
Figure 51. China mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. India mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe mRNA Shingles Vaccine Sales Market Share by Country in 2025
Figure 59. Europe mRNA Shingles Vaccine Revenue Market Share by Country (2020-2025)
Figure 60. Europe mRNA Shingles Vaccine Sales Market Share by Type (2020-2025)
Figure 61. Europe mRNA Shingles Vaccine Sales Market Share by Application (2020-2025)
Figure 62. Germany mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. France mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64. UK mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa mRNA Shingles Vaccine Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa mRNA Shingles Vaccine Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa mRNA Shingles Vaccine Sales Market Share by Application (2020-2025)
Figure 70. Egypt mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of mRNA Shingles Vaccine in 2025
Figure 76. Manufacturing Process Analysis of mRNA Shingles Vaccine
Figure 77. Industry Chain Structure of mRNA Shingles Vaccine
Figure 78. Channels of Distribution
Figure 79. Global mRNA Shingles Vaccine Sales Market Forecast by Region (2026-2031)
Figure 80. Global mRNA Shingles Vaccine Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global mRNA Shingles Vaccine Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global mRNA Shingles Vaccine Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global mRNA Shingles Vaccine Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global mRNA Shingles Vaccine Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of mRNA Shingles Vaccine
Figure 2. mRNA Shingles Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global mRNA Shingles Vaccine Sales Growth Rate 2020-2031 (Units)
Figure 7. Global mRNA Shingles Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. mRNA Shingles Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. mRNA Shingles Vaccine Sales Market Share by Country/Region (2024)
Figure 10. mRNA Shingles Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Non Self Amplifying Type
Figure 12. Product Picture of Self-Amplifying Type
Figure 13. Global mRNA Shingles Vaccine Sales Market Share by Type in 2025
Figure 14. Global mRNA Shingles Vaccine Revenue Market Share by Type (2020-2025)
Figure 15. mRNA Shingles Vaccine Consumed in Hospital
Figure 16. Global mRNA Shingles Vaccine Market: Hospital (2020-2025) & (Units)
Figure 17. mRNA Shingles Vaccine Consumed in Clinic
Figure 18. Global mRNA Shingles Vaccine Market: Clinic (2020-2025) & (Units)
Figure 19. mRNA Shingles Vaccine Consumed in CDC
Figure 20. Global mRNA Shingles Vaccine Market: CDC (2020-2025) & (Units)
Figure 21. mRNA Shingles Vaccine Consumed in Others
Figure 22. Global mRNA Shingles Vaccine Market: Others (2020-2025) & (Units)
Figure 23. Global mRNA Shingles Vaccine Sale Market Share by Application (2024)
Figure 24. Global mRNA Shingles Vaccine Revenue Market Share by Application in 2025
Figure 25. mRNA Shingles Vaccine Sales by Company in 2025 (Units)
Figure 26. Global mRNA Shingles Vaccine Sales Market Share by Company in 2025
Figure 27. mRNA Shingles Vaccine Revenue by Company in 2025 ($ millions)
Figure 28. Global mRNA Shingles Vaccine Revenue Market Share by Company in 2025
Figure 29. Global mRNA Shingles Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global mRNA Shingles Vaccine Revenue Market Share by Geographic Region in 2025
Figure 31. Americas mRNA Shingles Vaccine Sales 2020-2025 (Units)
Figure 32. Americas mRNA Shingles Vaccine Revenue 2020-2025 ($ millions)
Figure 33. APAC mRNA Shingles Vaccine Sales 2020-2025 (Units)
Figure 34. APAC mRNA Shingles Vaccine Revenue 2020-2025 ($ millions)
Figure 35. Europe mRNA Shingles Vaccine Sales 2020-2025 (Units)
Figure 36. Europe mRNA Shingles Vaccine Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa mRNA Shingles Vaccine Sales 2020-2025 (Units)
Figure 38. Middle East & Africa mRNA Shingles Vaccine Revenue 2020-2025 ($ millions)
Figure 39. Americas mRNA Shingles Vaccine Sales Market Share by Country in 2025
Figure 40. Americas mRNA Shingles Vaccine Revenue Market Share by Country (2020-2025)
Figure 41. Americas mRNA Shingles Vaccine Sales Market Share by Type (2020-2025)
Figure 42. Americas mRNA Shingles Vaccine Sales Market Share by Application (2020-2025)
Figure 43. United States mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC mRNA Shingles Vaccine Sales Market Share by Region in 2025
Figure 48. APAC mRNA Shingles Vaccine Revenue Market Share by Region (2020-2025)
Figure 49. APAC mRNA Shingles Vaccine Sales Market Share by Type (2020-2025)
Figure 50. APAC mRNA Shingles Vaccine Sales Market Share by Application (2020-2025)
Figure 51. China mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. India mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe mRNA Shingles Vaccine Sales Market Share by Country in 2025
Figure 59. Europe mRNA Shingles Vaccine Revenue Market Share by Country (2020-2025)
Figure 60. Europe mRNA Shingles Vaccine Sales Market Share by Type (2020-2025)
Figure 61. Europe mRNA Shingles Vaccine Sales Market Share by Application (2020-2025)
Figure 62. Germany mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. France mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64. UK mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa mRNA Shingles Vaccine Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa mRNA Shingles Vaccine Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa mRNA Shingles Vaccine Sales Market Share by Application (2020-2025)
Figure 70. Egypt mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries mRNA Shingles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of mRNA Shingles Vaccine in 2025
Figure 76. Manufacturing Process Analysis of mRNA Shingles Vaccine
Figure 77. Industry Chain Structure of mRNA Shingles Vaccine
Figure 78. Channels of Distribution
Figure 79. Global mRNA Shingles Vaccine Sales Market Forecast by Region (2026-2031)
Figure 80. Global mRNA Shingles Vaccine Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global mRNA Shingles Vaccine Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global mRNA Shingles Vaccine Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global mRNA Shingles Vaccine Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global mRNA Shingles Vaccine Revenue Market Share Forecast by Application (2026-2031)